Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy

NCT01847573 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
17
Enrollment
INDUSTRY
Sponsor class

Stopped Dosing stopped

Conditions

Interventions

Sponsor

Processa Pharmaceuticals